Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Beissbarth

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Genes, Chromosomes & Cancer|November 10, 2017
Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgeryYue Hu, Jochen Gaedcke, Georg Emons, et al.
The Oncologist|May 12, 2011
Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancerHendrik A Wolff, Lena-Christin Conradi, Markus Schirmer, et al.
Cancer Research|August 25, 2011
Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2BTanja Prenzel, Yvonne Begus-Nahrmann, Frank Kramer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2015
Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinomaMargret Rave-Fränk, Narges Tehrany, Julia Kitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2009
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapyJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Molecular Cell|July 7, 2015
MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMPXin Zhang, Ramona Schulz, Shelley Edmunds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2010
Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survivalThilo Sprenger, Franz Rödel, Tim Beissbarth, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
A gene expression signature for chemoradiosensitivity of colorectal cancer cellsMelanie Spitzner, Georg Emons, Frank Kramer, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomasJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 11, 2015
High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinomaNarges Tehrany, Julia Kitz, Margret Rave-Fränk, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Genes, Chromosomes & Cancer|November 10, 2017
Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgeryYue Hu, Jochen Gaedcke, Georg Emons, et al.
The Oncologist|May 12, 2011
Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancerHendrik A Wolff, Lena-Christin Conradi, Markus Schirmer, et al.
Cancer Research|August 25, 2011
Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2BTanja Prenzel, Yvonne Begus-Nahrmann, Frank Kramer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2015
Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinomaMargret Rave-Fränk, Narges Tehrany, Julia Kitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2009
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapyJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Molecular Cell|July 7, 2015
MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMPXin Zhang, Ramona Schulz, Shelley Edmunds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2010
Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survivalThilo Sprenger, Franz Rödel, Tim Beissbarth, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
A gene expression signature for chemoradiosensitivity of colorectal cancer cellsMelanie Spitzner, Georg Emons, Frank Kramer, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomasJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 11, 2015
High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinomaNarges Tehrany, Julia Kitz, Margret Rave-Fränk, et al.
Pageof 13